Seeking Alpha

  Actavis plc. (ACT) - NYSE

  • Jim Van Meerten | Send Message 25 Aug 2012

    ACT - 100% Barchart technical buy signal- 3 new highs and up 11.55% in the last month - Relative Strength Index 71.30%
      ACT vs. ETF Alternatives
      Company Description
      Actavis PLC specialty pharmaceutical company engaged in developing, manufacturing and distributing generic, brand and biosimilar products.
      Sector: Healthcare
      Industry: Drugs - Generic
      Country: United States